The Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV), led by the National Institutes of Health (NIH), is a public-private partnership that has made crucial contributions to the rapid-pace development of COVID-19 treatments and vaccines by, designing master protocols, establishing national standards, and identifying best practices and collaboration opportunities to improve every stage of the prevention and treatment R&D pipeline.
Coordinated by the Foundation for the National Institutes of Health (FNIH), ACTIV brings NIH together with its sibling agencies in the Department of Health and Human Services, including the Biomedical Advanced Research and Development Authority (BARDA), Centers for Disease Control and Prevention (CDC), and the U.S. Food and Drug Administration (FDA); other government agencies including the Department of Defense (DOD) and Department of Veterans Affairs (VA); The Operation (formerly known as Operation Warp Speed); the European Medicines Agency (EMA); and representatives from academia, philanthropic organizations, and numerous biopharmaceutical companies.
For more information about the Outstanding Achievement in Public Health Awards, generously supported by Johnson & Johnson, click here.